Antiretroviral News and Research

RSS

Panel backs routine HIV screenings for teens, adults

The U.S. Preventive Services Task Force advises that nearly everyone ages 15 to 64 should be screened for the HIV virus, a recommendation which, if adopted, would require Medicare and most private health insurers to pay for the tests.

21 Nov 2012

UNAIDS report shows progress due to 'unprecedented acceleration' in global AIDS response

UNAIDS' new World AIDS Day report: Results, released on Tuesday, "shows that unprecedented acceleration in the AIDS response is producing results for people," according to a UNAIDS press release.

21 Nov 2012

New intervention strategies needed to reach HIV-infected youth at birth

As youth infected at birth with HIV reach adolescence and young adulthood, a new study published in Clinical Infectious Diseases underscores the need to promote healthy behaviors as some of these young people become sexually active.

9 Nov 2012

Blog examines PEPFAR-funded program to improve access to HIV/AIDS treatment in Ethiopia

Writing in USAID's "IMPACTblog," Dereje Bisrat, monitoring and evaluation adviser for the Supply Chain Management System (SCMS), discusses the PEPFAR-funded program, which is administered by USAID and "works with Ethiopia's Pharmaceutical Fund and Supply Agency (PFSA), nine regional health bureaus, and more than 1,717 health facilities to improve access to HIV/AIDS treatment" in the country.

8 Nov 2012

Blog series on global AIDS blueprint interviews NIH investigator

As part of its "Blueprint" series discussing the creation of a U.S. global AIDS blueprint called for by Secretary of State Hillary Clinton in July, the Center for Global Health Policy's "Science Speaks" blog features an interview with Rochelle Walensky, a member of Cost-Effectiveness of Preventing AIDS Complications (CEPAC) and the Office of AIDS Research Advisory Council at the NIH/DHS Panel on Antiretroviral Guidelines for Adults and Adolescents.

3 Nov 2012

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

1 Nov 2012

Malawi needs donor support to maintain HIV/AIDS treatment program

In the last of a series of posts on the U.K. Department for International Development's (DfID) blog examining the department's work in Malawi, Neil Squires, DfID head of profession for health, looks at the sustainability of the country's HIV/AIDS program.

26 Oct 2012

Associated Press examines access to antiretroviral treatment in Myanmar

The Associated Press examines access to antiretroviral treatment in Myanmar, which "ranks among the world's hardest places to get HIV care, and health experts warn it will take years to prop up a broken health system hobbled by decades of neglect."

26 Oct 2012

USPTO issues patent to Tobira’s cenicriviroc for treatment of HIV-1 infection

Tobira Therapeutics, Inc., developer of innovative antiretroviral therapies for HIV, today announced the United States Patent and Trademark Office has issued patent 8,183,273, claiming compositions of matter of a broad family of compounds with activity against chemokine receptors CCR5 and CCR2.

26 Oct 2012

Cardiovascular disease risk varies with HIV subgroup

The ability of lipids to predict risk for cardiovascular disease may be weakened in women who are infected with HIV, report researchers.

23 Oct 2012

Bipartisan support for foreign assistance improves, saves lives abroad

Briefly recapping a history of foreign aid policy since 1920, former Sen. Blanche Lincoln (D-Ark.) and former Arkansas Gov. Mike Huckabee (R) write in a Politico opinion piece, "Credit for America's global leadership role belongs to both major political parties and Americans of all stripes" who "have always been guided by the notion that all lives have equal value, regardless of where someone was born."

22 Oct 2012

Mistakes are still commonly made in prescriptions of antiretroviral medications

Research presented at IDWeek 2012- concludes that despite advances in electronic medical records, mistakes are still commonly made in the prescription of antiretroviral medications for hospitalized HIV-positive patients. At the same time, a trio of studies suggests however, that electronic records in combination with increased clinical education can help to greatly decrease medical errors.

20 Oct 2012

Researchers concerned over likely rise in older people living with HIV in sub-Saharan Africa

"Sub-Saharan Africa is likely to see a more than 200 percent increase in the number of older people living with HIV in the next 30 years, thanks to improvements in life-saving treatment, experts said Thursday," Agence France-Presse reports.

20 Oct 2012

Canadian journal examines HIV in Swaziland

The Canadian Medical Association Journal reports on HIV in the Kingdom of Swaziland, writing the country "now has the dubious distinction of having the world's highest rate of both HIV and tuberculosis (TB)."

20 Oct 2012

Zimbabwe to allow trained nurses to prescribe, administer ARVs

PlusNews examines challenges and concerns over an announcement by the Zimbabwean government that it plans to train nurses to prescribe and administer antiretroviral drugs (ARVs) to people living with HIV in the country.

19 Oct 2012

Adults with HIV can benefit from cognitive training exercises

As more effective antiretroviral therapy has evolved over the past 30 years, HIV/AIDS has shifted from an acute to a chronic condition. But as patients live longer, research indicates that they are experiencing cognitive impairments at a higher rate than people without the disease.

17 Oct 2012

U.N. report shows francophone African countries lag behind in AIDS Treatment; NGOs call for increased funding

"Despite great progress within a short time, the 29 French-speaking countries of sub-Saharan Africa are lagging far behind other states in the region in the battle against HIV/AIDS and need a massive increase in international aid, according to a United Nations report" released Friday, the U.N. News Centre reports.

16 Oct 2012

Mylan, Shionogi and CIMA Labs to resolve generic Orapred ODT patent litigation

Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.

10 Oct 2012

Study examines trends in HIV mortality

Overall death rates due to human immunodeficiency virus (HIV) infection declined over time between 1993 and 2007 for most men and women by race/ethnicity and educational levels, with the largest absolute decreases for nonwhites, but rates remain high among blacks, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

9 Oct 2012

Zimbabwe set to attain 'universal' ARV coverage

"Zimbabwe is set to attain 'universal' coverage for AIDS treatment thanks in part to an $84 million disbursement on Tuesday by the United Nations-backed Global Fund to Fight AIDS, Tuberculosis and Malaria," the U.N. News Centre reports.

4 Oct 2012